Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 2/20 | 0.56 |
| ▸ | MAOB | P27338 | 6/20 | 0.54 |
| ▸ | MAOA | P21397 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | HPD | P32754 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.45 |
| ▸ | TLR4 | O00206 | 1/20 | 0.45 |
| ▸ | TLR2 | O60603 | 1/20 | 0.45 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6951337 | 0.90 | KMT2A (0.57) | NR4A2MAOBMAOAKMT2ASMN1; SMN2 | |
| SCHEMBL6946998 | 0.88 | MAOB (0.45) | NR4A2MAOBMAOAKMT2ASMN1; SMN2 | |
| SCHEMBL6472275 | 0.79 | MAOB (0.60) | NR4A2MAOBMAOAKMT2AMEN1 | |
| SCHEMBL6471083 | 0.78 | NR4A2 (0.61) | NR4A2MAOBMAOAKMT2AMEN1 | |
| SCHEMBL6947645 | 0.75 | MAOB (0.49) | MAOBMAOAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL2839915 | 0.74 | NR4A2 (0.56) | NR4A2MAOBMAOAKMT2AMEN1 | |
| SCHEMBL15340853 | 0.74 | MAOB (0.65) | NR4A2MAOBMAOAKMT2AMEN1 | |
| SCHEMBL1168262 | 0.72 | NR4A2 (1.00) | NR4A2MAOBKMT2AHPDSMN1; SMN2 | |
| SCHEMBL2499037 | 0.72 | MAOB (0.83) | NR4A2MAOBMAOAKMT2AMEN1 | |
| SCHEMBL6471015 | 0.72 | MAOB (0.56) | NR4A2MAOBMAOAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1082121-A4 | HIV INTEGRASE INHIBITORS | MERCK & CO INC (US) | 2003-02-05 | — | — | EP | claimed |
| EP-1082121-A1 | HIV INTEGRASE INHIBITORS | Merck & Co., Inc. (US) | 2001-03-14 | — | — | EP | claimed |
| WO-1999062520-A1 | HIV INTEGRASE INHIBITORS | MERCK & CO., INC. (US) | 1999-12-09 | — | — | WO | claimed |
| EP-1082121-A4 | HIV INTEGRASE INHIBITORS | MERCK & CO INC (US) | 2003-02-05 | — | — | EP | disclosed |
| EP-1082121-A1 | HIV INTEGRASE INHIBITORS | Merck & Co., Inc. (US) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999062520-A1 | HIV INTEGRASE INHIBITORS | MERCK & CO., INC. (US) | 1999-12-09 | — | — | WO | disclosed |